JP2024523329A5 - - Google Patents
Info
- Publication number
- JP2024523329A5 JP2024523329A5 JP2023577464A JP2023577464A JP2024523329A5 JP 2024523329 A5 JP2024523329 A5 JP 2024523329A5 JP 2023577464 A JP2023577464 A JP 2023577464A JP 2023577464 A JP2023577464 A JP 2023577464A JP 2024523329 A5 JP2024523329 A5 JP 2024523329A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- composition according
- viruses
- viral antigen
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211974P | 2021-06-17 | 2021-06-17 | |
| US63/211,974 | 2021-06-17 | ||
| US202163240278P | 2021-09-02 | 2021-09-02 | |
| US63/240,278 | 2021-09-02 | ||
| US202163275398P | 2021-11-03 | 2021-11-03 | |
| US63/275,398 | 2021-11-03 | ||
| PCT/US2022/034104 WO2022266511A1 (en) | 2021-06-17 | 2022-06-17 | Temperature-controllable, self-replicating rna vaccines for viral diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523329A JP2024523329A (ja) | 2024-06-28 |
| JP2024523329A5 true JP2024523329A5 (enExample) | 2025-06-10 |
Family
ID=84526756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577464A Pending JP2024523329A (ja) | 2021-06-17 | 2022-06-17 | ウイルス性疾患用の温度制御可能な自己複製ｒｎａワクチン |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240269268A1 (enExample) |
| EP (1) | EP4355880A4 (enExample) |
| JP (1) | JP2024523329A (enExample) |
| KR (1) | KR20240023600A (enExample) |
| AU (1) | AU2022294919A1 (enExample) |
| CA (1) | CA3221347A1 (enExample) |
| IL (1) | IL309038A (enExample) |
| MX (1) | MX2023014564A (enExample) |
| WO (1) | WO2022266511A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117003835A (zh) * | 2023-03-17 | 2023-11-07 | 成都威斯克生物医药有限公司 | 抗SARS-CoV-2奥密克戎突变株XBB及其亚型感染的蛋白及疫苗 |
| WO2026097106A1 (en) * | 2024-11-04 | 2026-05-07 | Purdue Research Foundation | Methods and compositions for universal influenza vaccination using an adenoviral vector |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211378B2 (en) * | 2002-01-31 | 2007-05-01 | Wisconsin Alumni Research Foundation | Filovirus vectors and noninfectious filovirus-based particles |
| CA2959105C (en) * | 2014-09-03 | 2023-10-17 | Bavarian Nordic A/S | Recombinant modified vaccinia virus ankara (mva) filovirus vaccine |
| WO2017015457A1 (en) * | 2015-07-21 | 2017-01-26 | Modernatx, Inc. | Ebola vaccine |
| MA46023A (fr) * | 2015-10-22 | 2019-07-03 | Modernatx Inc | Vaccin contre le virus de la grippe à large spectre |
| WO2018115527A2 (en) * | 2016-12-23 | 2018-06-28 | Curevac Ag | Mers coronavirus vaccine |
| WO2018170347A1 (en) * | 2017-03-17 | 2018-09-20 | Modernatx, Inc. | Zoonotic disease rna vaccines |
| WO2018185732A1 (en) * | 2017-04-06 | 2018-10-11 | Janssen Vaccines & Prevention B.V. | Mva-bn and ad26.zebov or ad26.filo prime-boost regimen |
| KR102764120B1 (ko) * | 2019-12-31 | 2025-02-06 | 엘릭서젠 쎄라퓨틱스, 인크. | 핵산 및 단백질의 세포 및 조직으로의 온도-기반 일시적 전달 |
| US20230310581A1 (en) * | 2020-04-27 | 2023-10-05 | Ohio State Innovation Foundation | A live attenuated measles virus vectored vaccine for sars-cov-2 |
| EP4168042A1 (en) * | 2020-06-19 | 2023-04-26 | Ziphius Vaccines | Self-amplifying sars-cov-2 rna vaccine |
-
2022
- 2022-06-17 MX MX2023014564A patent/MX2023014564A/es unknown
- 2022-06-17 WO PCT/US2022/034104 patent/WO2022266511A1/en not_active Ceased
- 2022-06-17 IL IL309038A patent/IL309038A/en unknown
- 2022-06-17 EP EP22825942.0A patent/EP4355880A4/en active Pending
- 2022-06-17 JP JP2023577464A patent/JP2024523329A/ja active Pending
- 2022-06-17 AU AU2022294919A patent/AU2022294919A1/en active Pending
- 2022-06-17 US US18/569,589 patent/US20240269268A1/en active Pending
- 2022-06-17 KR KR1020247001316A patent/KR20240023600A/ko active Pending
- 2022-06-17 CA CA3221347A patent/CA3221347A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116082521B (zh) | 痘病毒多抗原嵌合疫苗及其用途 | |
| JP2013501038A5 (enExample) | ||
| JPWO2012053646A1 (ja) | ワクシニアウイルスベクターおよびセンダイウイルスベクターからなるプライム／ブーストワクチン用ウイルスベクター | |
| JP2023521662A5 (enExample) | ||
| JP2022513326A5 (enExample) | ||
| US20250339511A1 (en) | Nucleic acid vaccine against monkeypox virus and use thereof | |
| JP2023522154A5 (enExample) | ||
| WO2023051701A1 (zh) | 抗SARS-CoV-2感染的mRNA、蛋白以及抗SARS-CoV-2感染的疫苗 | |
| WO2024140767A1 (zh) | 用于预防或治疗hpv感染相关疾病的多核苷酸分子 | |
| WO2021207848A1 (en) | Mers-cov vaccine | |
| JP2024537250A (ja) | インフルエンザワクチン | |
| CN113430178B (zh) | 一种表达ii型单纯疱疹病毒蛋白的重组流感病毒株及其制备方法与应用 | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| WO2006038742A1 (ja) | 組み換えウイルスおよびその用途 | |
| JP2024511356A5 (enExample) | ||
| CN101394868A (zh) | 重组腺病毒5型/35型和痘病毒mva活病毒载体疫苗的联用诱导强大的免疫应答的方法 | |
| WO2022245287A1 (en) | Amino acids, nucleotides and vectors expressing the same and uses thereof in preventing sarbecovirus infection | |
| JP2024540976A5 (enExample) | ||
| JP2005065596A (ja) | 増殖能欠損狂犬病ウイルス | |
| JP2023529836A5 (enExample) | ||
| CN112135908A (zh) | 选择性cd8阳性t细胞诱导疫苗抗原 | |
| JP2024525578A5 (enExample) | ||
| CN110204613A (zh) | 一种针对胡宁病毒的中和抗体、其制备方法及其应用 | |
| JP5699093B2 (ja) | パラポックスウイルス・オヴィスの組換えタンパク質およびそれ由来の医薬組成物 | |
| US20240239844A1 (en) | Combinations of viral proteins, peptide sequences, epitopes, and methods and uses thereof |